FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

U.S. FDA — The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Read the original at U.S. FDA ↗

Auto-published by the finit.news Events monitor from U.S. FDA; summarized by AI and may contain errors — verify against the primary source. August 25, 2026.

By